Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma
NCT05476484
Allergic Rhinitis, Allergy
Hørsholm, Copenhagen, Denmark
View Trial DetailsNCT Number: NCT00114881
Minority children who grow up in poor urban neighborhoods have the highest rates of asthma, and also experience greater morbidity from acute exacerbations of this disease. The aim of this study is to further identify environmental factors unique to the inner city that affect immune development and the expression of wheezing, atopy and asthma for purposes of identifying new strategies for asthma prevention.
Looking for future studies?
Notify MeAll sexes
Observational
Pediatric Clinical Research Unit, Johns Hopkins University, Baltimore, Maryland, United States
The purpose of this study is to determine the way environmental factors (like the components of inner-city household dust) affect immune system development and symptoms of asthma in inner city children. The study is divided into five periods, as the subjects age from birth to 17 years old. Each age bracket will explore different objectives and endpoints.
Study Objectives/Hypotheses:
-To determine the wheezing, asthma and atopy phenotypes in minority children growing up in poor urban neighborhoods as they develop from birth through adolescence.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Mothers:
Exclusion criteria
for Mothers:
Exclusion criteria
for Infants:
Time frame: 0 to 3 years of age
Establish in inner city children the immunologic causes for the development of recurrent wheezing.
Time frame: by 7 years of age
Establish, in this cohort of inner-city children, the immunologic causes for the development of asthma at age 7
Time frame: up to 10 years of age
Fully define the rapidly evolving asthma phenotypes and further delineate the role of risk factors related to environmental exposure (e.g.; house dust levels found through home inspection), immune development, lung growth on the natural history of asthma and allergic diseases in urban minority children
Time frame: up to 17 years of age
Number of participants with the incidence (development) of asthma
Time frame: up to 17 years of age
Further define asthma phenotypes based on the findings in Inner-city Asthma Consortium-19 (ICAC-19) (Asthma Phenotypes in the Inner City (APIC), ClinicalTrials.gov Identifier NCT01383941).
National Institute of Allergy and Infectious Diseases (NIAID)
Nih
Urban Environment and Childhood Asthma (URECA)
Acronym: URECA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05476484
Allergic Rhinitis, Allergy
Hørsholm, Copenhagen, Denmark
View Trial DetailsNCT04186949
Allergic Sensitisation, Allergy
Santiago, RM, Chile
View Trial DetailsNCT00894816
Allergy, Asthma
Umeå, Sweden
View Trial DetailsNCT03928561
Allergy, Asthma
Strasbourg, Bas-Rhin, France
View Trial Details